Fentanyl Delays the Platelet Inhibition Effects of Oral Ticagrelor: Full Report of the PACIFY Randomized Clinical Trial

Keyphrases

• Randomized Clinical Trial 100%
• Platelet Inhibition 100%
• Fentanyl 100%
• Inhibition Effect 100%
• Ticagrelor 100%
• P2Y12 40%
• Myocardial Infarction 20%
• Opioids 20%
• Post-percutaneous Coronary Intervention 20%
• Platelet Aggregation Inhibitors 20%
• High-sensitivity Troponin I 20%
• Adverse Outcomes 10%
• Morphine 10%
• Plasma Concentration 10%
• Coronary Angiography 10%
• Platelets 10%
• Concentration-time Curve 10%
• Drug Class 10%
• Cardiac Patients 10%
• Platelet Aggregation 10%
• Adenosine Diphosphate 10%
• Self-reported Pain 10%
• Clinical Trial Registry 10%
• Single Center 10%
• Myocardial Injury 10%
• First Responders 10%
• Light Transmission 10%
• Platelet Function 10%
• Coronary Stenting 10%
• Percutaneous Coronary Intervention 10%
• Drug Interactions 10%
• Intrathecal Midazolam 10%
• Troponin 10%
• Local Anesthetics 10%
• Platelet Aggregometry 10%
• Class Effect 10%
• Intrathecal Fentanyl 10%
• Self-reported Anxiety 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Randomized Clinical Trial 100%
• Ticagrelor 100%
• Duragesic 100%
• Troponin I 27%
• Opiate 18%
• Heart Infarction 18%
• Antithrombocytic Agent 18%
• Clinical Trial 9%
• Adverse Outcome 9%
• Morphine 9%
• Adenosine Diphosphate 9%
• Heart Muscle Injury 9%
• Midazolam 9%
• Drug Interaction 9%
• Local Anesthetic Agent 9%